MXCT
MaxCyteFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MXCT vs peer average
22/100
MXCT vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
CRDL is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $131.77M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MXCT
MaxCyte
CRDL
Cardiol Therapeutics
Grade
F
A
Momentum
19
91
Value
41
41
Sentiment
-
73
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs CRDL
MXCT / CRDL
Grade Position
Below peers
MXCT vs. peer average (F vs. C)
22/100
Momentum
19
CRDLValue
41
MXCTSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MXCT
CRDL is the first peer returned for this comparison set.

